Latest Pfizer Items
  • Pfizer banks on King Pharma's new painkillers

    Pfizer's purchase of King Pharmaceuticals announced Tuesday represents a $3.6 billion investment in an emerging class of painkillers that are designed to be less addictive than older pills such as OxyContin. The new products have been touted by federal health officials as an important way to curb prescription drug abuse, but they are relatively untested in the marketplace.

Happening Now